0001140361-16-088121.txt : 20161129
0001140361-16-088121.hdr.sgml : 20161129
20161129203403
ACCESSION NUMBER: 0001140361-16-088121
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161125
FILED AS OF DATE: 20161129
DATE AS OF CHANGE: 20161129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FUCHS HENRY J
CENTRAL INDEX KEY: 0001197355
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 162023875
MAIL ADDRESS:
STREET 1: C/O INTRABIOTICS PHARMACEUTICALS INC
STREET 2: 1245 TERRA BELLA AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc1.xml
FORM 4
X0306
4
2016-11-25
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001197355
FUCHS HENRY J
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO ST.
SAN RAFAEL
CA
94901
0
1
0
0
President, Worldwide R&D
Common Stock
2016-11-25
2016-11-25
4
M
0
15000
26.49
A
128878
D
Common Stock
2016-11-25
2016-11-25
4
S
0
15000
87.3992
D
113878
D
Stock Option (Right to buy Common Stock)
26.49
2016-11-25
2016-11-25
4
M
0
15000
0
D
2011-11-12
2021-05-11
Common Stock
15000
35225
D
Trade made pursuant to a 10b5-1 plan executed on May 12, 2016.
The price in column 4 is the weighted average price. The price actually received ranged from $86.67 to $88.06. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Reflects the number of stock options outstanding after the transaction from this specific stock option grant.
/s/ Laura Randall Woodhead, Attorney-in-Fact
2016-11-29